Charles W. Newton Lyell Immunopharma, Inc. (LYEL) insider trading activity
Charles W. Newton is Chief Financial Officer of Lyell Immunopharma, Inc.. Currently has a direct ownership of 172,725 shares of LYEL, which is worth approximately $93,271. The most recent transaction as insider was on Feb 10, 2025, when has been sold 112,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
173K
254.46%
3M change
254.46%
12M change
Total Value Held
$93,271
Charles W. Newton Transaction History
Also insider at
CWN
Charles W. Newton
Chief Financial Officer
South San Francisco, CA